Gaisböck Syndrome

Watchlist
Retrieved
2021-01-23
Source
Trials
Genes
Drugs

Gaisbock syndrome is characterised by secondary polycythemia.

Epidemiology

It occurs mainly in male sedentary individuals, on a high-calorie diet. Prevalence is unknown.

Clinical description

The clinical picture includes mild obesity, hypertension and decrease in plasma volume with relative increase in hematocrit, blood viscosity, serum cholesterol, triglycerides and uric acid. The reduction in plasma volume seems related to the elevation of the diastolic blood pressure.

Prognosis

Prognosis is impaired by the development of cardiovascular complications.